We are live on !
Find out more
EntryPoint Capital Portfolio holdings
AUM
$412M
Turnover
50.4%
1-Year Est. Return
28.52%
This Fund
S&P 500
This Quarter Est. Return
+15.49%
1 Year Est. Return
+28.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$412M
AUM Growth
+$70.8M
(+21%)
Cap. Flow
+$36.5M
Cap. Flow % of AUM
Cap. Flow %
8.87%
Top 10 Holdings %
Top 10 Hldgs %
4.34%
Holding
1,002
New
271
Increased
170
Reduced
168
Closed
234
Avg Time Held
0.4
years
Top 10 Avg Time Held
0
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Huntington Bancshares
HBAN
|
+$1.67M |
| 2 |
Donaldson
DCI
|
+$1.6M |
| 3 |
FedEx
FDX
|
+$1.6M |
| 4 |
Fidelity National Financial
FNF
|
+$1.53M |
| 5 |
Graco
GGG
|
+$1.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cadence Design Systems
CDNS
|
+$1.48M |
| 2 |
TIC Solutions Inc
TIC
|
+$1.48M |
| 3 |
Schrodinger
SDGR
|
+$1.27M |
| 4 |
Exelon
EXC
|
+$1.23M |
| 5 |
Visteon
VC
|
+$1.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 18% |
| 2 | Financials | 16.8% |
| 3 | Healthcare | 15.07% |
| 4 | Technology | 12.86% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
701
Satellogic
SATL
$597M
| $185K | 0.04% |
32,372
| – | – |
2026 Q1
1 quarter
|
|
702
Shattuck Labs
STTK
$566M
| $183K | 0.04% |
+26,387
| New | +$165K |
2026 Q2
0 quarters
|
|
703
BGC Group
BGC
$5.5B
| $183K | 0.04% |
+17,129
| New | +$192K |
2026 Q2
0 quarters
|
|
704
Universal Logistics Holdings
ULH
$433M
| $182K | 0.04% |
+12,312
| New | +$220K |
2026 Q2
0 quarters
|
|
705
Olema Pharmaceuticals
OLMA
$622M
| $181K | 0.04% |
+14,454
| New | +$194K |
2026 Q2
0 quarters
|
|
706
Nano Dimension
NNDM
$603M
| $181K | 0.04% |
124,568
+55,705
| +81% | +$91K |
2023 Q4
10 quarters
|
|
707
SunCoke Energy
SXC
$837M
| $177K | 0.04% |
21,971
-22,073
| -50% | -$171K |
2024 Q3
7 quarters
|
|
708
Geron
GERN
$758M
| $176K | 0.04% |
137,644
+38,570
| +39% | +$54.3K |
2025 Q4
2 quarters
|
|
709
Annexon
ANNX
$737M
| $176K | 0.04% |
30,787
-20,634
| -40% | -$114K |
2025 Q3
3 quarters
|
|
710
Limoneira
LMNR
$195M
| $175K | 0.04% |
13,291
+2,718
| +26% | +$35K |
2025 Q4
2 quarters
|
|
711
MiMedx Group
MDXG
$553M
| $173K | 0.04% |
44,915
+257
| +0.6% | +$938 |
2025 Q3
3 quarters
|
|
712
DXC Technology
DXC
$2.43B
| $171K | 0.04% |
19,310
| – | – |
2024 Q4
6 quarters
|
|
713
Zura Bio
ZURA
$395M
| $170K | 0.04% |
+28,806
| New | +$137K |
2026 Q2
0 quarters
|
|
714
Nomura Holdings
NMR
$26.9B
| $170K | 0.04% |
19,336
-55,837
| -74% | -$464K |
2023 Q4
10 quarters
|
|
715
Bioventus
BVS
$963M
| $167K | 0.04% |
17,732
-5,696
| -24% | -$54.4K |
2025 Q4
2 quarters
|
|
716
Palisade Bio
PALI
$246M
| $164K | 0.04% |
78,498
-997
| -1% | -$1.96K |
2026 Q1
1 quarter
|
|
717
Dentsply Sirona
XRAY
$1.77B
| $164K | 0.04% |
+15,426
| New | +$168K |
2026 Q2
0 quarters
|
|
718
Microvast
MVST
$194M
| $163K | 0.04% |
139,729
+17,241
| +14% | +$26.6K |
2026 Q1
1 quarter
|
|
719
Cabaletta Bio
CABA
$259M
| $158K | 0.04% |
+50,927
| New | +$167K |
2026 Q2
0 quarters
|
|
720
GoodRx Holdings
GDRX
$1.24B
| $156K | 0.04% |
+54,271
| New | +$138K |
2026 Q2
0 quarters
|
|
721
Granite Ridge Resources
GRNT
$752M
| $156K | 0.04% |
+35,386
| New | +$186K |
2026 Q2
0 quarters
|
|
722
StoneCo
STNE
$2.68B
| $155K | 0.04% |
14,298
| – | – |
2025 Q4
2 quarters
|
|
723
Vodafone
VOD
$36.6B
| $155K | 0.04% |
11,699
| – | – |
2025 Q4
2 quarters
|
|
724
ADMA Biologics
ADMA
$2.47B
| $152K | 0.04% |
18,144
-65,817
| -78% | -$600K |
2026 Q1
1 quarter
|
|
725
Stitch Fix
SFIX
$350M
| $150K | 0.04% |
36,413
-9,112
| -20% | -$33.1K |
2026 Q1
1 quarter
|
|
Similar funds
EntryPoint Capital's Q2 2026 Portfolio in Review
As of Q2 2026, EntryPoint Capital held 1,002 positions worth $412M, up 21% from $341M the previous quarter. Its ten largest holdings account for 4.3% of the portfolio.
EntryPoint Capital deployed $36.5M of net new capital in Q2 2026, opening 271 new positions and adding to 170 existing holdings. Its largest new stake was Huntington Bancshares: 101,010 shares worth $1.79M.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Cadence Design Systems, an estimated $1.48M trimmed.
- EntryPoint Capital's largest Q2 2026 buy was Huntington Bancshares: 101,010 shares worth $1.79M.
- EntryPoint Capital added most to Gilead Sciences in Q2 2026, an estimated $1.51M increase.
- EntryPoint Capital's biggest Q2 2026 reduction was Cadence Design Systems, cutting an estimated $1.48M.
- EntryPoint Capital fully exited Exelon in Q2 2026, selling an estimated $1.23M.
- EntryPoint Capital's ten largest holdings make up 4.3% of its $412M portfolio in Q2 2026.
- EntryPoint Capital opened 271 new positions and closed 234 in Q2 2026.
- EntryPoint Capital's portfolio value rose 21% quarter-over-quarter to $412M.
Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.